Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
RANI
RANI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RANI News
Biotech Stocks Soar in After-Hours Trading: TCMD, BDSX, and EXAS Take the Lead
Nov 04 2025
NASDAQ.COM
Insider Buying Update for Tuesday, October 28: RANI and KO
Oct 28 2025
NASDAQ.COM
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
3 Penny Stocks to Keep an Eye On as of October 22, 2025
Oct 22 2025
TipRanks
HC Wainwright & Co. Initiates Coverage on Rani Therapeutics Holdings with a Buy Rating and Sets Price Target at $11
Oct 21 2025
Benzinga
Maxim Group Reaffirms Buy Rating for Rani Therapeutics Holdings, Increases Price Target to $10
Oct 20 2025
Benzinga
Most Active Stocks in Pre-Market on October 20, 2025: REPL, RANI, TSLL, SQQQ, BITF, NUAI, ACHR, NIO, BBAI, IONQ, LAC, CLF
Oct 20 2025
NASDAQ.COM
Major Stock Movers on Monday: PLUG, RANI, and Others
Oct 20 2025
SeekingAlpha
What Caused This Penny Biotech Stock to Surge 250%?
Oct 20 2025
TipRanks
Friday's Major Stock Market Highlights: Morning News Summary!
Oct 17 2025
TipRanks
What’s Behind Rani Therapeutics' 150% Surge in Stock Price Today?
Oct 17 2025
TipRanks
Rani Therapeutics Reveals Successful $60.3 Million Private Placement Exceeding Expectations, Priced According to Nasdaq Regulations
Oct 17 2025
Newsfilter
Rani Therapeutics Soars Following Chugai Licensing Agreement and Private Placement
Oct 17 2025
SeekingAlpha
Rani Therapeutics raises $60.3 million in private funding to support pipeline development until 2028.
Oct 17 2025
SeekingAlpha
Rani (RANI) Q2 Net Loss Improves 16%
Aug 07 2025
NASDAQ.COM
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
Jul 15 2025
Benzinga
Show More News
